Recherche des images sur Google Monographie du produit
Liste d'ingrédient(s) actif(s):
- irinotecan (irinotecan sucrose octasulfate), 4.3 MG/ML
DIN: 02467135
Forme(s) posologique(s): SUSPENSION
Voie(s) d'administration: INTRAVEINEUSE
Description: LIPOSOMES FOR INJECTION. SINGLE USE VIAL
Annexe: Prescription
Entreprise: IPSEN BIOPHARMACEUTICALS CANADA INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS (ATC, WHO)
- L01CE - (ATC, WHO)
- L01CE02 - IRINOTECAN (WHO)